SOFIA (Bulgaria), September 16 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Wednesday that its CEO - Ognyan Donev, further increased his interest in the company through a single transaction on the regulated market of the Bulgarian Stock Exchange on September 15.